Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECOVERY: A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions of Native Coronary Artery

NCT02542007 is registered in ClinicalTrials.gov with OrbusNeich as lead sponsor.

NCT NCT02542007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02542007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECOVERY: A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions of Native Coronary Artery
Lead sponsor
OrbusNeich
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
June 10, 2021
Enrollment
440 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis